CVS Group (LON:CVSG) Insider David Wilton Buys 1,500 Shares of Stock

CVS Group plc (LON:CVSG) insider David Wilton purchased 1,500 shares of CVS Group stock in a transaction on Tuesday, August 4th. The shares were acquired at an average cost of GBX 1,276 per share, with a total value of £19,140.

CVS Group Stock Performance

LON CVSG traded up GBX 8 on Wednesday, hitting GBX 1,288. 191,841 shares of the company’s stock traded hands, compared to its average volume of 971,484. The firm’s 50-day moving average price is GBX 1,230.89 and its two-hundred day moving average price is GBX 1,243.04. The firm has a market capitalization of £891.30 million, a PE ratio of 18.69, a P/E/G ratio of 1.77 and a beta of 1.06. The company has a current ratio of 1.07, a quick ratio of 0.90 and a debt-to-equity ratio of 92.34. CVS Group plc has a 1-year low of GBX 1,062 and a 1-year high of GBX 1,648.

CVS Group declared that its board has initiated a share repurchase plan on Tuesday, May 26th that allows the company to buyback 0 shares. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board of directors believes its stock is undervalued.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on CVSG shares. Jefferies Financial Group boosted their price objective on CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a report on Friday, July 31st. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 1,700 price target on shares of CVS Group in a research report on Monday, July 27th. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 2,000 price target on shares of CVS Group in a report on Thursday, July 23rd. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, CVS Group presently has an average rating of “Moderate Buy” and a consensus price target of GBX 1,720.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.